Every research site that has a strong CRO track record was once a new site with no history. The path from zero history to a competitive performance record is predictable, but it requires strategic choices about which studies to pursue first, how to execute them operationally, and what to document so that the performance data exists for future feasibility responses.

Start With Lower-Competition Study Types

Phase IV studies, observational studies, and registry studies are less competitive than Phase II and Phase III trials for site placement. The per-patient fees are lower, but the protocol complexity is also lower — which means a new site has a higher probability of executing cleanly and building a strong initial performance record. A new site with two completed observational studies showing clean data quality metrics and 90 percent enrollment of target is a more credible candidate for a Phase III selection than a new site with no history at all.

Build the Operational Infrastructure Before the First Study Opens

The sites that build strong track records from their first study do so because the operational infrastructure — enrollment tracking, coordinator workflows, scheduling automation, physician outreach — is in place before the first patient is consented. A new site that activates and then figures out its recruitment strategy is almost certain to have a slow first-patient-in and a sub-optimal enrollment rate. A new site that has a physician outreach program running before activation, a pre-screening workflow configured, and an enrollment tracking system ready demonstrates organizational capability that translates directly into first-study performance.

Document Everything Systematically

Performance data only helps future feasibility responses if it is captured and stored. Sites should track, by study: physician contacts made, physician referral conversion rate, pre-screening volume, screen failure rate, enrollment vs. target each month, query rate, and deviation rate. This data, accumulated across two or three studies, transforms a new site's feasibility response from a set of projections to a data-backed performance argument.

Respond to Every Feasibility Questionnaire, Even the Ones You Do Not Win

CRO selection processes are relationship-building opportunities even when the site is not selected. A site that responds thoughtfully to a feasibility questionnaire — demonstrating that it has real patient population data and operational infrastructure — gets remembered by the clinical operations manager who reviewed the response. Returning that questionnaire within 48 hours with strong documentation, even for a study the site does not win, establishes the site's name in the CRO's operational consciousness for future opportunities.